-
Xiaoxiao Li (Electrical and Computer Engineering, The University of British Columbia)29/05/2024, 13:30Physics in Medicine and Biology / Physique en médecine et en biologie (DPMB-DPMB)Invited Speaker / Conférencier(ère) invité(e)
The challenges posed by small and heterogeneous medical datasets significantly impede AI development in biomedical data analysis. My research addresses this issue by utilizing innovative partially personalized federated learning frameworks. These frameworks facilitate collaborative learning across multiple medical centers, enhancing the development of precise, personalized AI models. In this...
Go to contribution page -
April Khademi (TMU Electrical, Computer, and Biomedical Engineering)29/05/2024, 14:15Symposia Day (DPMB/DAPI - DPMB/DPAI) - Medical Imaging / Imagerie médicaleInvited Speaker / Conférencier(ère) invité(e)
Medical images play a critical role in patient management and are used to decide treatment; they also comprise nearly 80% of all hospital data. We have an opportunity to leverage AI in medical imaging, to change the way medicine is practiced. AI tools for medical imaging can offer more accurate diagnosis, improve inter-rater agreement across specialists, and reduce turn-around-time -- all...
Go to contribution page -
Logan Mackay (TRIUMF / University of Edinburgh)29/05/2024, 14:45Symposia Day (DPMB/DAPI - DPMB/DPAI) - Medical Imaging / Imagerie médicaleOral not-in-competition (Undergraduate Student) / Orale non-compétitive (Étudiant(e) du 1er cycle)
Targeted Alpha Therapy (TAT) is a mode of cancer treatment in which alpha-emitting radionuclides attached to selective delivery molecules are injected into patients to preferentially kill cancer cells, a promising candidate radionuclide is actinium-225. Due to the relatively low radio-activities used (MBq’s) in this treatment and the absence of positron emissions in actinium-225’s decay chain,...
Go to contribution page
Choose timezone
Your profile timezone: